BioRestorative Therapies
BRTX
12 hedge funds and large institutions have $1.36M invested in BioRestorative Therapies in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
41% more capital invested
Capital invested by funds: $966K → $1.36M (+$391K)
0.38% more ownership
Funds ownership: 7.53% → 7.91% (+0.38%)
14% less funds holding
Funds holding: 14 → 12 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$144K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$55.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$7.1K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.79K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$957 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$57.9K |
| 2 |
Two Sigma Advisers
New York
|
-$13.4K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.26K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $560K | +$4.79K | +1,000 | +0.8% |
|
|
WA
2
Wealth Alliance
Mellville,
New York
| $195K | – | – | – |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $193K | +$144K | +30,078 | +220% |
|
4
Mariner
Overland Park,
Kansas
| $118K | – | – | – |
|
|
5
Two Sigma Advisers
New York
| $116K | -$13.4K | -2,800 | -10% |
|
6
State Street
Boston,
Massachusetts
| $90.2K | – | – | – |
|
|
7
Wells Fargo
San Francisco,
California
| $51K | +$55.2K | +11,540 | +52,455% |
|
|
8
UBS Group
Zurich,
Switzerland
| $13.6K | +$7.1K | +1,484 | +93% |
|
|
SPIA
9
Steward Partners Investment Advisory
New York
| $8.82K | – | – | – |
|
|
10
Osaic Holdings
Scottsdale,
Arizona
| $8.35K | +$957 | +200 | +12% |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $3.26K | -$2.26K | -472 | -39% |
|
|
JWM
12
Janiczek Wealth Management
Denver,
Colorado
| $5 | – | – | – |
|
|
13
Two Sigma Investments
New York
| – | -$57.9K | -17,026 | Closed |
|
BRTX Hedge Fund Activity: Q2 2023 in Review
12 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in BioRestorative Therapies (BRTX) for Q2 2023, worth a combined $1.36M — up 41% from $966K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BRTX and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 5 added.
The largest buyer was Geode Capital Management, adding an estimated $144K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $57.9K sold.
- 12 institutional investors held BioRestorative Therapies (BRTX) as of Q2 2023, down from 14 in Q1 2023.
- Funds reported $1.36M of BioRestorative Therapies stock for Q2 2023, up 41% quarter-over-quarter.
- 0 funds opened new BioRestorative Therapies positions in Q2 2023 and 1 closed out, a net change of -1 holder.
- The largest BioRestorative Therapies buyer in Q2 2023 was Geode Capital Management, an estimated $144K added.
- The largest BioRestorative Therapies seller in Q2 2023 was Two Sigma Investments, an estimated $57.9K sold.
Based on aggregated 13F filings for Q2 2023.